Lai Leng Yew
Direktor/Vorstandsmitglied bei GDS GLOBAL LIMITED
Profil
Lai Leng Yew is an Independent Non-Executive Director at GDS Global Ltd.
and Director-Business Development at NeoAsia (S) Pte Ltd.
She previously worked as a Regional Manager-Business Development at Zuellig Pharma Asia Pacific Ltd.
and as a Vice President-Business Development at Axcynsis Therapeutics Pte Ltd.
Ms. Yew completed her undergraduate degree at the University of Keele.
Aktive Positionen von Lai Leng Yew
Unternehmen | Position | Beginn |
---|---|---|
GDS GLOBAL LIMITED | Direktor/Vorstandsmitglied | 25.10.2023 |
NeoAsia (S) Pte Ltd. | Corporate Officer/Principal | 01.10.2023 |
Ehemalige bekannte Positionen von Lai Leng Yew
Unternehmen | Position | Ende |
---|---|---|
Axcynsis Therapeutics Pte Ltd.
Axcynsis Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Axcynsis Therapeutics Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company focuses on developing antibody-x conjugate (AXC) therapies to revolutionize cancer treatments. The company is leveraging proprietary technologies to develop a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options. The company was founded in 2022 by Zou Bin, who has been the CEO since 2022. | Corporate Officer/Principal | 01.07.2023 |
Zuellig Pharma Asia Pacific Ltd.
Zuellig Pharma Asia Pacific Ltd. Medical DistributorsDistribution Services Zuellig Pharma Asia Pacific Ltd. engages in the manufacture and distribution of pharmaceutical and healthcare products. The company is headquartered in Hong Kong. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Lai Leng Yew
University of Keele | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GDS GLOBAL LIMITED | Producer Manufacturing |
Private Unternehmen | 3 |
---|---|
NeoAsia (S) Pte Ltd. | |
Axcynsis Therapeutics Pte Ltd.
Axcynsis Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Axcynsis Therapeutics Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company focuses on developing antibody-x conjugate (AXC) therapies to revolutionize cancer treatments. The company is leveraging proprietary technologies to develop a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options. The company was founded in 2022 by Zou Bin, who has been the CEO since 2022. | Commercial Services |
Zuellig Pharma Asia Pacific Ltd.
Zuellig Pharma Asia Pacific Ltd. Medical DistributorsDistribution Services Zuellig Pharma Asia Pacific Ltd. engages in the manufacture and distribution of pharmaceutical and healthcare products. The company is headquartered in Hong Kong. | Distribution Services |